Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million - BioLegacy Research

Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million

Post author:Sam
Post published:May 18, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace